BridgeBio Pharma Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Sep 2018 | — | $-41.5M | $-42.1M |
| Mar 2019 | — | $-63.8M | $-69.4M |
| Jun 2019 | — | $-69.3M | $-74.3M |
| Sep 2019 | $26.7M | $-54.5M | $-60.7M |
| Mar 2020 | — | $-102.5M | $-104.1M |
| Jun 2020 | — | $-124.6M | $-136.2M |
| Sep 2020 | $8.1M | $-119.9M | $-130.2M |
| Mar 2021 | $462.0K | $-167.5M | $-171.1M |
| Jun 2021 | $54.0M | $-94.0M | $-102.1M |
| Sep 2021 | $2.3M | $-149.5M | $-161.0M |
| Mar 2022 | $1.7M | $-173.7M | $-201.3M |
| Jun 2022 | $73.7M | $-80.2M | $-2.6M |
| Sep 2022 | $338.0K | $-129.1M | $-140.2M |
| Mar 2023 | $1.8M | $-126.2M | $-142.7M |
| Jun 2023 | $1.6M | $-146.1M | $-160.7M |
| Sep 2023 | $4.1M | $-157.7M | $-179.5M |
| Mar 2024 | $211.1M | $343.0K | $-36.2M |
| Jun 2024 | $2.2M | $-175.5M | $-75.5M |
| Sep 2024 | $2.7M | $-191.8M | $-164.3M |
| Mar 2025 | $116.6M | $-104.4M | $-169.6M |
| Jun 2025 | $110.6M | $-134.3M | $-183.8M |
| Sep 2025 | $120.7M | $-145.2M | $-184.9M |
| Mar 2026 | $194.5M | $-106.0M | $-166.6M |
| Jun 2026 | $243.7M | $-107.1M | $-155.9M |